PREPIDIL INTRACERVICAL, gel sterile intracervical syringe, 2.5 ml
Active ingredients: Prostaglandin E2
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Gel sterilesyringe, 2.5 mlintracervicale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PREPIDIL INTRACERVICAL, gel stérile intracervical
- Pharmaceutical form
- gel stérile
- Route of administration
- intracervicale
- Presentation description
- 1 seringue(s) préremplie(s) polyéthylène de 2,5 ml avec cathéter(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Aug 1988
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64421236CIP75559120CIP133400955591207Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DINOPROSTONEgel | 0,5 mg · une seringue pré-remplie de 2,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.